Fund+ Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals

  • Investments
  • 34

  • Portfolio
  • 16

  • Exits
  • 7

Exits

Fund+ General Information

Description

Founded in 2015, Fund+ is a venture capital firm based in Leuven, Belgium. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm prefers to invest in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors in Belgium.

Contact Information

Website
www.fundplus.be
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Groot Begijnhof 60
  • 3000 Leuven
  • Belgium
+32 016 00 00 00

Fund+ Investments (34)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
AstriVax 25-Aug-2022 Seed Round 000.00 Drug Discovery Pre-Clinical Trials 00000000 000000000 00.0
0000000 23-Aug-2022 00000 00000 000.00 Biotechnology Generating Revenue 000000000 00000 00.0
0000000 31-May-2022 00000 00000 000.00 Drug Discovery Generating Revenue 00000000 00000000 00.0
0000000 24-May-2022 00000 00000 000.00 Biotechnology Generating Revenue 00000000 00000000 00.0
0000000 03-May-2022 00000 00000 000.00 Biotechnology Generating Revenue 000 000 000 0000000
000000 18-Feb-2022 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 000 000 000 0000000
00000ï00 18-Jan-2022 00000 00000 Drug Discovery Clinical Trials - Phase 2
0000 000000 22-Dec-2021 00000 00000 000.00 Drug Discovery Generating Revenue 00000 00000
Coave Therapeutics 02-Dec-2021 Later Stage VC 000.00 Drug Delivery Generating Revenue 00000000 00000000 00.0
Egle Therapeutics 22-Oct-2021 Early Stage VC 000.00 Drug Discovery Generating Revenue 00000000 00000000 00.0
You’re viewing 10 of 34 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fund+ Exits (7)

Company Name Exit Date Exit Type Exit Size
Aelin Therapeutics 07-Jul-2023 Out of Business
0000000 00000000 01-Jan-2022 000000000 00000000
00000 000000000000 24-Jul-2020 000 00000
0000000 0000000000 12-Apr-2019 0000000 000000
00000 16-May-2017 000000000000000000 00000
AmatsiQBiologicals 25-Jan-2016 Buyout/LBO
Masthercell 27-Feb-2015 Merger/Acquisition 000.00
To view Fund+’s complete exits history, request access »

Fund+ Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Fund+ Team (9)

Name Title Deals Funds Boards Office
Bart De Leeuw Partner & Chief Financial Officer Leuven, Belgium
Philippe Monteyne Ph.D Senior Partner 0 0 Leuven, Belgium
Caroline Goddeeris Ph.D Partner 0 0 Leuven, Belgium
Halina Novak Ph.D Senior Associate Leuven, Belgium
Lawrence Van Helleputte Ph.D Associate Leuven, Belgium
You’re viewing 5 of 9 team members. Get the full list »